Assessment of Information to Substantiate a Health Claim on the Prevention of Prostate Cancer by Lignans
Open Access
Abstract
Lignans and their in vivo metabolites, especially enterolactone (ENL), have attracted substantial interest as potential chemopreventive agents for prostate cancer. Preclinical and clinical interventions performed with lignan-rich flaxseed that use surrogate biomarkers as endpoints suggest that lignans may attenuate prostate carcinogenesis in individuals with increased risk or with diagnosed cancer. No unequivocal prostate cancer risk reduction has been found for lignans in epidemiological studies, suggesting that lignan concentrations found in populations consuming a regular non-supplemented diet are not chemopreventive in prostate cancer. Presumably, the main obstacles in assessing the efficacy of food lignans is limited knowledge of the serum and tissue lignan concentrations required for the putative prevention. Further clinical studies performed with the purified compounds are required to substantiate a health claim.Keywords
This publication has 68 references indexed in Scilit:
- Increased Endogenous Estrogen Synthesis Leads to the Sequential Induction of Prostatic Inflammation (Prostatitis) and Prostatic Pre-MalignancyThe American Journal of Pathology, 2009
- Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic CohortBritish Journal of Cancer, 2009
- Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and NutritionBritish Journal of Cancer, 2009
- Enterolactone Inhibits Insulin-Like Growth Factor-1 Receptor Signaling in Human Prostatic Carcinoma PC-3 CellsThe Journal of Nutrition, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Vitamins E and C in the Prevention of Prostate and Total Cancer in MenJAMA, 2009
- Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men PresurgeryCancer Epidemiology, Biomarkers & Prevention, 2008
- Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitroMolecular Nutrition & Food Research, 2008
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2008
- Variability in anticancer lignan levels in flaxseedNutrition and Cancer, 1997